Skull Smash
FDA sniffs out unapproved claims company’s smelling salts increase alertness, focus, and more.
Griffin et al. v. Benefytt Technologies, Inc. (f/k/a Health Insurance Innovations, Inc.) and Health Plan Intermediaries Holdings, Inc.
20-cv-62371, S.D. Fla.
(May 2020)
Medical insurance policies
Marketing policies as comprehensive medical insurance when they are limited benefit plans
Pending
FDA sniffs out unapproved claims company’s smelling salts increase alertness, focus, and more.
Why this piano man may not give you the keys to success.
Dig into these advertising claims.
Advisory opinion letter raises “serious concerns” with self-reg group’s guidance.
Emily Jankowski and Grace Tatter, WBUR | NPR